Consolidated Statement Of Income

Medrx Co.,Ltd. - Filing #7339301

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Consolidated statement of income
Statement of income
Net sales
JPY
6,963,000 JPY
Cost of sales
JPY
2,400,000 JPY
Operating expenses
Operating expenses - general
Depreciation
570,000 JPY
583,000 JPY
Operating expenses
Selling, general and administrative expenses
176,076,000 JPY
299,530,000 JPY
Operating expenses
Operating profit (loss)
-176,076,000 JPY
-294,967,000 JPY
Ordinary profit (loss)
-127,811,000 JPY
-289,171,000 JPY
Gross profit (loss)
JPY
4,563,000 JPY
Net sales
General and administrative expenses
Operating expenses
Research and development expenses
121,107,000 JPY
237,362,000 JPY
Cost of sales
Non-operating income
Interest income
10,000 JPY
3,000 JPY
Other
6,000 JPY
496,000 JPY
Non-operating income
55,539,000 JPY
11,517,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Non-operating expenses
7,274,000 JPY
5,721,000 JPY
Share issuance costs
144,000 JPY
785,000 JPY
Profit (loss) before income taxes
-127,811,000 JPY
-289,171,000 JPY
Gross profit
Income taxes - current
495,000 JPY
1,372,000 JPY
Income taxes - deferred
-36,000 JPY
-36,000 JPY
Income taxes
459,000 JPY
1,336,000 JPY
Profit (loss)
-128,270,000 JPY
-290,508,000 JPY
Profit (loss) attributable to owners of parent
-128,270,000 JPY
-290,508,000 JPY
Other comprehensive income
Foreign currency translation adjustment
-357,000 JPY
-2,978,000 JPY
Other comprehensive income
-357,000 JPY
-2,978,000 JPY
Profit attributable to
Comprehensive income
-128,627,000 JPY
-293,486,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-128,627,000 JPY
-293,486,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.